These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 16445896)

  • 1. Blocking intrahepatic deletion of activated CD8+ T cells by an altered peptide ligand.
    Kuniyasu Y; Qamar A; Sheikh SZ; Jhandier MN; Hakim W; Mehal WZ
    Cell Immunol; 2005 Nov; 238(1):31-7. PubMed ID: 16445896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kupffer cells required for high affinity peptide-induced deletion, not retention, of activated CD8+ T cells by mouse liver.
    Kuniyasu Y; Marfani SM; Inayat IB; Sheikh SZ; Mehal WZ
    Hepatology; 2004 Apr; 39(4):1017-27. PubMed ID: 15057906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CTLA-4 ablation and interleukin-12 driven differentiation synergistically augment cardiac pathogenicity of cytotoxic T lymphocytes.
    Love VA; Grabie N; Duramad P; Stavrakis G; Sharpe A; Lichtman A
    Circ Res; 2007 Aug; 101(3):248-57. PubMed ID: 17569889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early intrahepatic antigen-specific retention of naïve CD8+ T cells is predominantly ICAM-1/LFA-1 dependent in mice.
    Bertolino P; Schrage A; Bowen DG; Klugewitz K; Ghani S; Eulenburg K; Holz L; Hogg N; McCaughan GW; Hamann A
    Hepatology; 2005 Nov; 42(5):1063-71. PubMed ID: 16250049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular CD154 expression reflects antigen-specific CD8+ t cells but shows less sensitivity than intracellular cytokine and MHC tetramer staining.
    Han YW; Aleyas AG; George JA; Yoon HA; Lee JH; Kim BS; Eo SK
    J Microbiol Biotechnol; 2007 Dec; 17(12):1955-64. PubMed ID: 18167442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative PCR for detection of the OT-1 transgene.
    Wright KO; Murray DA; Crispe NI; Pierce RH
    BMC Immunol; 2005 Aug; 6():20. PubMed ID: 16120215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective retention of activated CD8+ T cells by the normal liver.
    Mehal WZ; Juedes AE; Crispe IN
    J Immunol; 1999 Sep; 163(6):3202-10. PubMed ID: 10477588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic T-cell response following mouse liver transplantation is independent of the initial site of T-cell priming.
    Klein I; Gassel HJ; Crispe IN
    Transplant Proc; 2006 Dec; 38(10):3241-3. PubMed ID: 17175235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining the ability of cyclophosphamide preconditioning to enhance the antigen-specific CD8+ T-cell response to peptide vaccination: creation of a beneficial host microenvironment involving type I IFNs and myeloid cells.
    Salem ML; Kadima AN; El-Naggar SA; Rubinstein MP; Chen Y; Gillanders WE; Cole DJ
    J Immunother; 2007 Jan; 30(1):40-53. PubMed ID: 17198082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TNFR2-deficient memory CD8 T cells provide superior protection against tumor cell growth.
    Kim EY; Teh SJ; Yang J; Chow MT; Teh HS
    J Immunol; 2009 Nov; 183(10):6051-7. PubMed ID: 19841176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4 T cell help is required for primary CD8 T cell responses to vesicular antigen delivered to dendritic cells in vivo.
    Serre K; Giraudo L; Siret C; Leserman L; Machy P
    Eur J Immunol; 2006 Jun; 36(6):1386-97. PubMed ID: 16673447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CD8 T cell response to vaccinia virus exhibits site-dependent heterogeneity of functional responses.
    Xiao Z; Curtsinger JM; Prlic M; Jameson SC; Mescher MF
    Int Immunol; 2007 Jun; 19(6):733-43. PubMed ID: 17545279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type 1 CD8+ T cells are superior to type 2 CD8+ T cells in tumor immunotherapy due to their efficient cytotoxicity, prolonged survival and type 1 immune modulation.
    Ye Z; Tang C; Xu S; Zhang B; Zhang X; Moyana T; Yang J; Xiang J
    Cell Mol Immunol; 2007 Aug; 4(4):277-85. PubMed ID: 17764618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active CD4+ helper T cells directly stimulate CD8+ cytotoxic T lymphocyte responses in wild-type and MHC II gene knockout C57BL/6 mice and transgenic RIP-mOVA mice expressing islet beta-cell ovalbumin antigen leading to diabetes.
    Ye Z; Ahmed KA; Hao S; Zhang X; Xie Y; Munegowda MA; Meng Q; Chibbar R; Xiang J
    Autoimmunity; 2008 Nov; 41(7):501-11. PubMed ID: 18855194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The duration of TCR/pMHC interactions regulates CTL effector function and tumor-killing capacity.
    Riquelme E; Carreño LJ; González PA; Kalergis AM
    Eur J Immunol; 2009 Aug; 39(8):2259-69. PubMed ID: 19637198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonal restriction of the expansion of antigen-specific CD8+ memory T cells by transforming growth factor-{beta}.
    Cheng ML; Chen HW; Tsai JP; Lee YP; Shih YC; Chang CM; Ting CC
    J Leukoc Biol; 2006 May; 79(5):1033-42. PubMed ID: 16478921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4+CD25+ regulatory T cells are activated in vivo by recognition of self.
    Andersson J; Stefanova I; Stephens GL; Shevach EM
    Int Immunol; 2007 Apr; 19(4):557-66. PubMed ID: 17369190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil-dependent tumor rejection and priming of tumoricidal CD8+ T cell response induced by dendritic cells overexpressing CD95L.
    Buonocore S; Haddou NO; Moore F; Florquin S; Paulart F; Heirman C; Thielemans K; Goldman M; Flamand V
    J Leukoc Biol; 2008 Sep; 84(3):713-20. PubMed ID: 18567840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B7-H1 on hepatocytes facilitates priming of specific CD8 T cells but limits the specific recall of primed responses.
    Wahl C; Bochtler P; Chen L; Schirmbeck R; Reimann J
    Gastroenterology; 2008 Sep; 135(3):980-8. PubMed ID: 18621049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of CTL function among high-avidity tumor-specific CD8+ T cells following tumor infiltration.
    Janicki CN; Jenkinson SR; Williams NA; Morgan DJ
    Cancer Res; 2008 Apr; 68(8):2993-3000. PubMed ID: 18413769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.